1. Home
  2. GSIW vs PMN Comparison

GSIW vs PMN Comparison

Compare GSIW & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GSIW

Garden Stage Limited

HOLD

Current Price

$0.15

Market Cap

28.6M

Sector

N/A

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$14.46

Market Cap

23.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSIW
PMN
Founded
2016
2004
Country
Hong Kong
Canada
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.6M
23.5M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
GSIW
PMN
Price
$0.15
$14.46
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$42.67
AVG Volume (30 Days)
536.0K
442.7K
Earning Date
01-01-0001
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,087,497.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
515.58
N/A
52 Week Low
$0.09
$6.27
52 Week High
$1.79
$39.75

Technical Indicators

Market Signals
Indicator
GSIW
PMN
Relative Strength Index (RSI) 49.42 67.71
Support Level $0.11 $8.96
Resistance Level $0.16 $17.40
Average True Range (ATR) 0.01 1.94
MACD -0.00 0.09
Stochastic Oscillator 68.62 50.96

Price Performance

Historical Comparison
GSIW
PMN

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong; and I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: